Yen, Hsin-Yung http://orcid.org/0000-0002-6612-3324
Liko, Idlir
Song, Wanling
Kapoor, Parth
Almeida, Fernando
Toporowska, Joanna
Gherbi, Karolina
Hopper, Jonathan T. S.
Charlton, Steven J. http://orcid.org/0000-0001-8841-2752
Politis, Argyris http://orcid.org/0000-0002-6658-3224
Sansom, Mark S. P. http://orcid.org/0000-0001-6360-7959
Jazayeri, Ali http://orcid.org/0000-0002-6212-4442
Robinson, Carol V. http://orcid.org/0000-0001-7829-5505
Funding for this research was provided by:
RCUK | Biotechnology and Biological Sciences Research Council (BB/L002558/1)
Leverhulme Trust (RPG-2019-178, RPG-2019-178)
Wellcome Trust (092970/Z/10/Z, 221795/Z/20/Z)
Article History
Received: 6 December 2021
Accepted: 9 August 2022
First Online: 10 November 2022
Competing interests
: H.-Y.Y was an employee, and I.L., P.K., F.A., K.G, J.T.S.H., S.J.C. and A.J. are current employees of OMass Therapeutics. C.V.R is founder and consultant of OMass Therapeutics. All other authors declare no competing interests.